WE WAIT FOR RESULTS, on dosing. Then it is all out. FDA, approves and PHASE 3. BAM! POW! KA-BOOOONMMMM!
New board member...
You have to ask yourself why would this accomplished and experienced Doctor and oncologist who is a specialist in this field risk her reputation on TROV for a seemingly few shares if she does not see great potential for future development.
I think they had 7.7 million before the 7.1 offering. If so, that is about 3.5 to 4 quarters of cash based on the 3.9 costs of last quarter. That is not counting any increase in revenue...
Can I get a peer check on this from someone??
A close in the low 70's would be sweet..
Dr. Athena Countouriotis
Has some resume!
HA! HA! NEWBIE KNOWS ALL! bash-TURDING
Nice to hear from you Grow!
GATHERING up FORCES; soon will have to approach FDA... PHASE 3..... All about CREDIBILITY!
Strengthens board of directors!
Enjoy the day and week....
Woah! Have you really never heard of the best trading site, the stock DORK? It is one of the top trading sites on the internet today. Have a look at the*stock-dork .
Almost felt sorry for Welch during that last conference in NYC - he was assigned the coveted 5-5:30 time slot when most attendees minds have already checked out for dinner. Then, a 26 slide Powerpoint that was allotted about 7 or 8 minutes - followed by polite applause. Pretty sure it was a waste of time.
For the people who post things like trovagene has given up liquid biopsy testing , here is proof that they're putting out bad and dangerous post.. They also have deals with two large biopharmaceutical companies. Aster Zenaca is one and they have not released the name of other yet. They are still doing their own in-house liquid biopsy testing besides doing it for other major companies. All of the information is right there on their website.
Big pharma is the way for now. it's a lot safer and less expensive to take blood and urine then it is tissue biopsies. And the Trovera test proves in some cancers mutations to be more accurate than tissue biopsy. If AstraZeneca is satisfied along with other Bio Pharm Companies, Trovagene is on their way! If PCM 075 is successful we are looking at the start of a very very successful lucrative company. If? I'm in for 4 years and hanging on. I'm taking the gamble.
We have agreements with two large international pharmaceutical companies to provide our CLIA/CAP-accredited tests and laboratory testing services. Both companies plan to use our Trovera® liquid biopsy tests as biomarkers to evaluate patients’ response to therapy in their clinical trials. We anticipate performing CLIA laboratory testing with other clinical research organizations. We also continue to provide access to our Trovera® urine and blood single gene EGFR, KRAS and BRAF tests for physicians and their patients.
We need some good news...
This one is a big Buy don't be fooled by that legal investigation once this gets clear we are on the move with some good profits here.
TROV is definitely trading like it wants to be delisted. Someone must want in for a lot cheaper than this. Actually, we should already be delisted by now. The stock is on life support right now and has no chance of gaining financing at these levels to support it's upcoming trials.
Any ideas what might happen after secondary offering lockup expiration on September 27?